Cargando…
Physiological Level Production of Antigen-Specific Human Immunoglobulin in Cloned Transchromosomic Cattle
Therapeutic human polyclonal antibodies (hpAbs) derived from pooled plasma from human donors are Food and Drug Administration approved biologics used in the treatment of a variety of human diseases. Powered by the natural diversity of immune response, hpAbs are effective in treating diseases caused...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813428/ https://www.ncbi.nlm.nih.gov/pubmed/24205120 http://dx.doi.org/10.1371/journal.pone.0078119 |
_version_ | 1782289102039678976 |
---|---|
author | Sano, Akiko Matsushita, Hiroaki Wu, Hua Jiao, Jin-An Kasinathan, Poothappillai Sullivan, Eddie J. Wang, Zhongde Kuroiwa, Yoshimi |
author_facet | Sano, Akiko Matsushita, Hiroaki Wu, Hua Jiao, Jin-An Kasinathan, Poothappillai Sullivan, Eddie J. Wang, Zhongde Kuroiwa, Yoshimi |
author_sort | Sano, Akiko |
collection | PubMed |
description | Therapeutic human polyclonal antibodies (hpAbs) derived from pooled plasma from human donors are Food and Drug Administration approved biologics used in the treatment of a variety of human diseases. Powered by the natural diversity of immune response, hpAbs are effective in treating diseases caused by complex or quickly-evolving antigens such as viruses. We previously showed that transchromosomic (Tc) cattle carrying a human artificial chromosome (HAC) comprising the entire unrearranged human immunoglobulin heavy-chain (hIGH) and kappa-chain (hIGK) germline loci (named as κHAC) are capable of producing functional hpAbs when both of the bovine immunoglobulin mu heavy-chains, bIGHM and bIGHML1, are homozygously inactivated (double knockouts or DKO). However, B lymphocyte development in these Tc cattle is compromised, and the overall production of hpAbs is low. Here, we report the construction of an improved HAC, designated as cKSL-HACΔ, by incorporating all of the human immunoglobulin germline loci into the HAC. Furthermore, for avoiding the possible human-bovine interspecies incompatibility between the human immunoglobulin mu chain protein (hIgM) and bovine transmembrane α and β immunoglobulins (bIgα and bIgβ) in the pre-B cell receptor (pre-BCR) complex, we partially replaced (bovinized) the hIgM constant domain with the counterpart of bovine IgM (bIgM) that is involved in the interaction between bIgM and bIgα/Igβ; human IgM bovinization would also improve the functionality of hIgM in supporting B cell activation and proliferation. We also report the successful production of DKO Tc cattle carrying the cKSL-HACΔ (cKSL-HACΔ/DKO), the dramatic improvement of B cell development in these cattle and the high level production of hpAbs (as measured for the human IgG isotype) in the plasma. We further demonstrate that, upon immunization by tumor immunogens, high titer tumor immunogen-specific human IgG (hIgG) can be produced from such Tc cattle. |
format | Online Article Text |
id | pubmed-3813428 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-38134282013-11-07 Physiological Level Production of Antigen-Specific Human Immunoglobulin in Cloned Transchromosomic Cattle Sano, Akiko Matsushita, Hiroaki Wu, Hua Jiao, Jin-An Kasinathan, Poothappillai Sullivan, Eddie J. Wang, Zhongde Kuroiwa, Yoshimi PLoS One Research Article Therapeutic human polyclonal antibodies (hpAbs) derived from pooled plasma from human donors are Food and Drug Administration approved biologics used in the treatment of a variety of human diseases. Powered by the natural diversity of immune response, hpAbs are effective in treating diseases caused by complex or quickly-evolving antigens such as viruses. We previously showed that transchromosomic (Tc) cattle carrying a human artificial chromosome (HAC) comprising the entire unrearranged human immunoglobulin heavy-chain (hIGH) and kappa-chain (hIGK) germline loci (named as κHAC) are capable of producing functional hpAbs when both of the bovine immunoglobulin mu heavy-chains, bIGHM and bIGHML1, are homozygously inactivated (double knockouts or DKO). However, B lymphocyte development in these Tc cattle is compromised, and the overall production of hpAbs is low. Here, we report the construction of an improved HAC, designated as cKSL-HACΔ, by incorporating all of the human immunoglobulin germline loci into the HAC. Furthermore, for avoiding the possible human-bovine interspecies incompatibility between the human immunoglobulin mu chain protein (hIgM) and bovine transmembrane α and β immunoglobulins (bIgα and bIgβ) in the pre-B cell receptor (pre-BCR) complex, we partially replaced (bovinized) the hIgM constant domain with the counterpart of bovine IgM (bIgM) that is involved in the interaction between bIgM and bIgα/Igβ; human IgM bovinization would also improve the functionality of hIgM in supporting B cell activation and proliferation. We also report the successful production of DKO Tc cattle carrying the cKSL-HACΔ (cKSL-HACΔ/DKO), the dramatic improvement of B cell development in these cattle and the high level production of hpAbs (as measured for the human IgG isotype) in the plasma. We further demonstrate that, upon immunization by tumor immunogens, high titer tumor immunogen-specific human IgG (hIgG) can be produced from such Tc cattle. Public Library of Science 2013-10-24 /pmc/articles/PMC3813428/ /pubmed/24205120 http://dx.doi.org/10.1371/journal.pone.0078119 Text en © 2013 Sano et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Sano, Akiko Matsushita, Hiroaki Wu, Hua Jiao, Jin-An Kasinathan, Poothappillai Sullivan, Eddie J. Wang, Zhongde Kuroiwa, Yoshimi Physiological Level Production of Antigen-Specific Human Immunoglobulin in Cloned Transchromosomic Cattle |
title | Physiological Level Production of Antigen-Specific Human Immunoglobulin in Cloned Transchromosomic Cattle |
title_full | Physiological Level Production of Antigen-Specific Human Immunoglobulin in Cloned Transchromosomic Cattle |
title_fullStr | Physiological Level Production of Antigen-Specific Human Immunoglobulin in Cloned Transchromosomic Cattle |
title_full_unstemmed | Physiological Level Production of Antigen-Specific Human Immunoglobulin in Cloned Transchromosomic Cattle |
title_short | Physiological Level Production of Antigen-Specific Human Immunoglobulin in Cloned Transchromosomic Cattle |
title_sort | physiological level production of antigen-specific human immunoglobulin in cloned transchromosomic cattle |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813428/ https://www.ncbi.nlm.nih.gov/pubmed/24205120 http://dx.doi.org/10.1371/journal.pone.0078119 |
work_keys_str_mv | AT sanoakiko physiologicallevelproductionofantigenspecifichumanimmunoglobulininclonedtranschromosomiccattle AT matsushitahiroaki physiologicallevelproductionofantigenspecifichumanimmunoglobulininclonedtranschromosomiccattle AT wuhua physiologicallevelproductionofantigenspecifichumanimmunoglobulininclonedtranschromosomiccattle AT jiaojinan physiologicallevelproductionofantigenspecifichumanimmunoglobulininclonedtranschromosomiccattle AT kasinathanpoothappillai physiologicallevelproductionofantigenspecifichumanimmunoglobulininclonedtranschromosomiccattle AT sullivaneddiej physiologicallevelproductionofantigenspecifichumanimmunoglobulininclonedtranschromosomiccattle AT wangzhongde physiologicallevelproductionofantigenspecifichumanimmunoglobulininclonedtranschromosomiccattle AT kuroiwayoshimi physiologicallevelproductionofantigenspecifichumanimmunoglobulininclonedtranschromosomiccattle |